Personalis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Personalis and other ETFs, options, and stocks.About PSNL
Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives.
CEOChristopher M. Hall
CEOChristopher M. Hall
Employees229
Employees229
HeadquartersFremont, California
HeadquartersFremont, California
Founded2011
Founded2011
Employees229
Employees229
PSNL Key Statistics
Market cap850.75M
Market cap850.75M
Price-Earnings ratio-10.91
Price-Earnings ratio-10.91
Dividend yield—
Dividend yield—
Average volume1.53M
Average volume1.53M
High today$10.48
High today$10.48
Low today$9.43
Low today$9.43
Open price$10.45
Open price$10.45
Volume1.44M
Volume1.44M
52 Week high$11.40
52 Week high$11.40
52 Week low$2.83
52 Week low$2.83
Stock Snapshot
The current Personalis(PSNL) stock price is $9.68, with a market capitalization of 850.75M. The stock trades at a price-to-earnings (P/E) ratio of -10.91.
As of 2025-12-05, Personalis(PSNL) stock has fluctuated between $9.43 and $10.48. The current price stands at $9.68, placing the stock +2.7% above today's low and -7.6% off the high.
Personalis(PSNL) shares are trading with a volume of 1.44M, against a daily average of 1.53M.
In the last year, Personalis(PSNL) shares hit a 52-week high of $11.40 and a 52-week low of $2.83.
In the last year, Personalis(PSNL) shares hit a 52-week high of $11.40 and a 52-week low of $2.83.
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
People also own
Based on the portfolios of people who own PSNL. This list is generated using Robinhood data, and it’s not a recommendation.